))
Episode 37 - Lomustine: A Brief Overview
Архивные серии ("Канал не активен" status)
When?
This feed was archived on March 29, 2024 20:02 (
Why? Канал не активен status. Нашим серверам не удалось получить доступ к каналу подкаста в течении длительного периода времени.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 353512189 series 3416783
Контент предоставлен Brain Cancer Podcast. Весь контент подкастов, включая выпуски, графику и описания подкастов, загружается и предоставляется непосредственно Brain Cancer Podcast или его партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
Hello and welcome! In this episode, we go over the latest step in my current treatment and discuss what lomustine is, potential side effects, and a story of how much control some companies have over our treatments.
I'm sorry for the slight delay in releasing this episode. I've been working, going to appointments, and my voice has been pretty rough the past week or so. That makes recording just not something I could have done.
I also normalized the audio to the industry standard because I'm still learning things here! I hope it sounds ok and that the volume is balanced from start to finish with nothing being too loud or quiet. Please let me know if there are any issues.
Thank you all so much for your support and being the greatest group of people. I practice gratitude every day and it helps me so much.
Links from the show:
https://chemocare.com/chemotherapy/drug-info/Lomustine.aspx
https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/alkylating-agent
https://www.drugs.com/drug-class/alkylating-agents.html
https://cancerletter.com/trials-and-tribulations/20210716_7/
https://www.cbsnews.com/news/brain-cancer-drug-gleostine-no-longer-an-option-under-medicare/
https://journals.lww.com/neurotodayonline/fulltext/2021/09160/a_glioblastoma_drug_is_abruptly_withdrawn_from.6.aspx
52 эпизодов
Поделиться
